Pure Himalayan Shilajit - Get 50% Off X
Tafmune EM is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Based on research, the following side effects have been observed when Tafmune EM is used -
Moderate
Mild
Is the use of Tafmune EM safe for pregnant women?
Pregnant women can take Tafmune EM without worrying about any side effects.
Is the use of Tafmune EM safe during breastfeeding?
Side effects of Tafmune EM for breastfeeding are little to none, so you can take it without doctor's advice.
What is the effect of Tafmune EM on the Kidneys?
Very few cases of side effects of Tafmune EM on kidney have been reported.
What is the effect of Tafmune EM on the Liver?
Tafmune EM has very mild side effects on the liver.
What is the effect of Tafmune EM on the Heart?
Side effects of Tafmune EM rarely affect the heart.
Tafmune EM should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Tafmune EM unless your doctor advises you to do so -
Is this Tafmune EM habit forming or addictive?
Forming a habit of Tafmune EM has not been reported.
Interaction between Food and Tafmune EM
Taking Tafmune EM with food does not cause any problems.
Interaction between Alcohol and Tafmune EM
Taking alcohol with Tafmune EM can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Emtriva®(emtricitabine)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1179
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 803-804
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Viread® (tenofovir disoproxil fumarate)